Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-01

FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone Bitartrate and Homatropine Methylbromide, an opioid cough suppressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone Bitartrate and Homatropine Methylbromide (Hydrocodone Bitartrate and Homatropine Methylbromide)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)